Gilead Sciences (GILD) Goodwill (2009 - 2026)

Gilead Sciences has reported Goodwill for 18 years, with the latest figure at $8.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Goodwill changed 0.0% year-over-year to $8.3 billion; the trailing twelve-month figure through Mar 2026 stood at $8.3 billion (changed 0.0% YoY), and the FY2025 full-year result was $8.3 billion, changed 0.0% from the prior year.
• Goodwill for Q1 2026 stood at $8.3 billion, roughly flat from $8.3 billion in the prior quarter.
• The five-year high for Goodwill was $8.3 billion in Q1 2022, with the low at $8.3 billion in Q1 2022.
• Historically, Goodwill has averaged $8.3 billion across 5 years, with a median of $8.3 billion in 2022.
• Annual changes were most pronounced in 2022 — Goodwill decreased 0.24% — and 2023, when it changed 0.0%.
• Gilead Sciences' Goodwill stood at $8.3 billion in 2022, then changed by 0.0% to $8.3 billion in 2023, then changed by 0.0% to $8.3 billion in 2024, then changed by 0.0% to $8.3 billion in 2025, then changed by 0.0% to $8.3 billion in 2026.
• The last three Goodwill figures came in at $8.3 billion (Q1 2026), $8.3 billion (Q4 2025), and $8.3 billion (Q3 2025), per Business Quant data.